HealthcareServices

m-RNA Synthesis Service Market Growth Opportunities: Insights from 2025–2029

November 13, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The m-RNA Synthesis Service Industry Compare Between 2025 And 2029?

The m-rna synthesis service market size has experienced considerable expansion in recent years. It is projected to increase from $4.54 billion in 2024 to $4.99 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The market’s historical growth can be linked to the escalating demand for personalized medicine and gene therapies, the expansion of clinical trials, the increasing prevalence of infectious diseases, growing investment in biotechnology, and a heightened focus on vaccine development.

The m-rna synthesis service market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.22 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.7%. Key factors driving this growth during the forecast period include the increasing adoption of mRNA therapies, the expanding applications of mRNA technology, a growing emphasis on mRNA therapeutics for autoimmune diseases, the continuous rise in demand for mRNA-based vaccines, and the surging demand for custom mRNA synthesis solutions. Significant trends expected during this period involve advancements in RNA polymerase enzyme engineering, the development of next-generation mRNA vaccines, increased automation in mRNA production, the emergence of personalized mRNA therapies, and the integration of AI and machine learning in mRNA design.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24611&type=smp

What Are The Drivers Pushing New Developments In The m-RNA Synthesis Service Market?

The mRNA synthesis service market is projected to experience growth due to the escalating interest in personalized medicine. Personalized medicine denotes a medical approach that customizes treatment plans and healthcare choices according to an individual’s unique genetic characteristics, lifestyle, and environmental factors. This rise in personalized medicine is attributable to advancements in genomic sequencing, which enable a more precise identification of specific genetic variations linked to illnesses and responses to treatment. mRNA synthesis services support the heightened focus on personalized medicine by facilitating the swift and accurate creation of mRNA-based therapies that are specifically designed for a person’s genetic makeup, leading to more effective and targeted interventions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that in 2023, the FDA sanctioned 16 new personalized treatments for patients with rare diseases, marking a significant increase from 6 in 2022. Within these approvals, seven were designated as cancer drugs, and three were formulated for various other diseases and conditions. Hence, the increasing emphasis on personalized medicine is propelling the expansion of the mRNA synthesis service market.

How Is The m-RNA Synthesis Service Market Classified Into Different Segments?

The m-rna synthesis service market covered in this report is segmented –

1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis

2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics

3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines

2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support

Which Ongoing Trends Are Expected To Shape The m-RNA Synthesis Service Market Outlook?

Leading companies active in the mRNA synthesis service market are prioritizing the development of innovative solutions, such as RNA polymerase advancements, to elevate the efficiency, output, and safety of mRNA production. RNA polymerase innovations involve creating advanced enzymes that enhance the transcription process, minimize undesirable effects like double-stranded RNA formation, and improve the overall quality of mRNA for vaccines and therapeutic applications. For example, in March 2025, Primrose Bio Inc., a US-based biotechnology company, launched Prima RNApols to boost the efficiency and scalability of mRNA synthesis. This enzyme features improved processivity and high-fidelity transcription, allowing it to generate longer and more stable mRNA strands with fewer errors. Its robust performance within in vitro transcription systems reduces impurities and increases overall yield, providing a dependable and scalable solution for companies involved in mRNA-based drug development. This innovation is especially valuable in the expanding sector of personalized medicine, where precise and efficient mRNA synthesis is crucial.

Who Are The Primary Competitors In The Global m-RNA Synthesis Service Market?

Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report

What Are The Key Regional Factors Influencing The m-RNA Synthesis Service Market Growth?

North America was the largest region in the m-RNA synthesis service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The m-RNA Synthesis Service Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24611&type=smp

Browse Through More Reports Similar to the Global m-RNA Synthesis Service Market 2025, By The Business Research Company

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

C Reactive Protein Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Genotyping Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795